51ºÚÁϳԹÏÍø

ISSN: 2167-0846

Journal of Pain & Relief
51ºÚÁϳԹÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Perioperative use of ketamine for pain management

International Conference and Exhibition on Pain Medicine

Yatish Siddapura Ranganath

Posters-Accepted Abstracts: J Pain Relief

DOI:

Abstract
Pain management with opioids is often limited by adverse effects and sometimes by ineffectiveness in an opioid-tolerant patient. Adjuvant treatment with an inexpensive opioid-sparing drug such as ketamine may help to provide better analgesia with fewer adverse effects. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is shown to be useful in a variety of surgical patients. Perioperative ketamine in sub anesthetic doses reduces postoperative opioid requirements, postoperative nausea or vomiting (PONV), rescue analgesic requirements, and pain intensity. Ketamine has multiple mechanisms of action, including but not limited to decreasing central excitability, decreasing acute postoperative opiate tolerance, and a possible modulation of opiate receptors. Adverse effects for perioperative ketamine are mild or absent. Postop pain management can be especially challenging in patients with preexisting chronic pain because of underlying factors such as psychiatric disorders (depression/anxiety), opioid tolerance, and opioid-induced hyperalgesia. Ketamine may be most efficacious in patients who consume higher amounts of preoperative opiate medications. Studies have also shown that ketamine may reduce pain intensity and analgesic consumption up to 6 weeks in the postoperative period. Postsurgical pain typically resolves by 4 weeks and a reduction in pain intensity at 6 weeks would represent a potential reduction in chronic postsurgical pain, an outcome of interest to primary care physicians, surgeons, and anesthesiologists. Evidence suggests that postoperative pain continues to be undermanaged and poorly controlled acute postoperative pain is associated with an increased risk of developing chronic postsurgical pain and cardiopulmonary complications. Multimodal therapy, including opioids, non-opioid adjunctive medications (ketamine, NSAIDs, acetaminophen, and anticonvulsants), along with regional anesthetic techniques may often be required to minimize potential complications related to suboptimal pain management. The presentation will discuss the usefulness of low dose ketamine in the perioperative setting, highlighting its use in the opioid-tolerant patient.
Biography
Relevant Topics
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top